Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (121-130 of 217) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 6, 2021
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinomaEo Jin Kim, Changhoon Yoo, Hyo Jeong Kang, et al.
American Journal of Clinical Oncology|August 8, 2012
Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01Yong Sang Hong, Kyung Hae Jung, Hwa Jung Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancerYong Sang Hong, Hye Ok Kim, Kyu-pyo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score AnalysisYoung Seob Shin, Chang Sik Yu, Jin-Hong Park, et al.
Oncology|May 5, 2012
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activityYoon Hee Choi, Tae Won Kim, Kyu-Pyo Kim, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumorChanghoon Yoo, Hyungwoo Cho, Min Jeong Song, et al.
Cancer Research and Treatment|June 20, 2024
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal AdenocarcinomaYoo Na Lee, Min Kyu Sung, Dae Wook Hwang, et al.
Cancer Research and Treatment|October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized TrialsJaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
Cancers|February 15, 2022
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITYJwa Hoon Kim, Changhoon Yoo, Seyoung Seo, et al.
JAMA Network Open|October 1, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical TrialHyehyun Jeong, Changhoon Yoo, Ilhwan Kim, et al.
Pageof 22

Showing results (121-130 of 217) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|February 6, 2021
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinomaEo Jin Kim, Changhoon Yoo, Hyo Jeong Kang, et al.
American Journal of Clinical Oncology|August 8, 2012
Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01Yong Sang Hong, Kyung Hae Jung, Hwa Jung Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancerYong Sang Hong, Hye Ok Kim, Kyu-pyo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score AnalysisYoung Seob Shin, Chang Sik Yu, Jin-Hong Park, et al.
Oncology|May 5, 2012
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activityYoon Hee Choi, Tae Won Kim, Kyu-Pyo Kim, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2016
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumorChanghoon Yoo, Hyungwoo Cho, Min Jeong Song, et al.
Cancer Research and Treatment|June 20, 2024
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal AdenocarcinomaYoo Na Lee, Min Kyu Sung, Dae Wook Hwang, et al.
Cancer Research and Treatment|October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized TrialsJaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
Cancers|February 15, 2022
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITYJwa Hoon Kim, Changhoon Yoo, Seyoung Seo, et al.
JAMA Network Open|October 1, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical TrialHyehyun Jeong, Changhoon Yoo, Ilhwan Kim, et al.
Pageof 22